Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA | 9 | 2023 | 88 | 2.910 |
Why?
|
| Ribonucleoproteins | 7 | 2023 | 15 | 2.830 |
Why?
|
| RNA Interference | 8 | 2020 | 76 | 1.970 |
Why?
|
| RNA, Small Interfering | 7 | 2022 | 109 | 1.830 |
Why?
|
| Oligonucleotides, Antisense | 6 | 2019 | 30 | 1.720 |
Why?
|
| DNA Repeat Expansion | 4 | 2020 | 5 | 1.670 |
Why?
|
| Nucleic Acid Conformation | 9 | 2020 | 46 | 1.430 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 77 | 1.410 |
Why?
|
| Microsatellite Repeats | 3 | 2020 | 25 | 1.380 |
Why?
|
| DNA | 5 | 2020 | 204 | 1.340 |
Why?
|
| Archaeal Proteins | 5 | 2012 | 5 | 1.280 |
Why?
|
| Cell Nucleus | 3 | 2016 | 109 | 1.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2020 | 173 | 1.040 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2020 | 62 | 1.030 |
Why?
|
| Genetic Vectors | 2 | 2022 | 118 | 1.000 |
Why?
|
| Nucleic Acids | 2 | 2021 | 6 | 0.990 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 481 | 0.980 |
Why?
|
| Cloning, Molecular | 2 | 2022 | 75 | 0.950 |
Why?
|
| Base Sequence | 11 | 2020 | 242 | 0.940 |
Why?
|
| RNA, Double-Stranded | 3 | 2019 | 6 | 0.920 |
Why?
|
| RNA, Nuclear | 2 | 2014 | 2 | 0.920 |
Why?
|
| Monkeypox | 1 | 2023 | 1 | 0.920 |
Why?
|
| Frontotemporal Dementia | 3 | 2020 | 7 | 0.910 |
Why?
|
| RNA, Bacterial | 2 | 2019 | 4 | 0.850 |
Why?
|
| Ribose | 1 | 2021 | 1 | 0.830 |
Why?
|
| Endodeoxyribonucleases | 1 | 2021 | 3 | 0.830 |
Why?
|
| Gene Targeting | 2 | 2021 | 17 | 0.810 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2020 | 4 | 0.780 |
Why?
|
| Aptamers, Nucleotide | 1 | 2020 | 9 | 0.780 |
Why?
|
| Biological Assay | 1 | 2020 | 16 | 0.770 |
Why?
|
| Viral Proteins | 1 | 2020 | 45 | 0.760 |
Why?
|
| RNA, Archaeal | 3 | 2009 | 3 | 0.740 |
Why?
|
| Genome, Human | 2 | 2020 | 129 | 0.690 |
Why?
|
| Reference Standards | 1 | 2019 | 30 | 0.690 |
Why?
|
| Oligonucleotides | 3 | 2019 | 27 | 0.660 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 143 | 0.650 |
Why?
|
| Endonucleases | 1 | 2018 | 4 | 0.650 |
Why?
|
| Nerve Tissue Proteins | 5 | 2013 | 118 | 0.650 |
Why?
|
| Nuclear Proteins | 4 | 2011 | 72 | 0.640 |
Why?
|
| Proteins | 2 | 2016 | 140 | 0.630 |
Why?
|
| Huntington Disease | 5 | 2019 | 14 | 0.620 |
Why?
|
| G-Quadruplexes | 2 | 2020 | 8 | 0.620 |
Why?
|
| RNA, Antisense | 2 | 2016 | 3 | 0.590 |
Why?
|
| Humans | 26 | 2023 | 29295 | 0.580 |
Why?
|
| Molecular Mimicry | 1 | 2016 | 2 | 0.580 |
Why?
|
| RNA, Plant | 1 | 2016 | 2 | 0.580 |
Why?
|
| Metals | 1 | 2016 | 16 | 0.570 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 71 | 0.560 |
Why?
|
| Base Pair Mismatch | 1 | 2016 | 7 | 0.560 |
Why?
|
| RNA Editing | 1 | 2015 | 3 | 0.550 |
Why?
|
| Models, Molecular | 6 | 2020 | 178 | 0.550 |
Why?
|
| Methanococcales | 2 | 2012 | 2 | 0.520 |
Why?
|
| Molecular Biology | 1 | 2015 | 7 | 0.520 |
Why?
|
| Lead | 1 | 2015 | 6 | 0.520 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2012 | 13 | 0.510 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 16 | 0.510 |
Why?
|
| Autoantigens | 2 | 2014 | 16 | 0.510 |
Why?
|
| Cell Fractionation | 1 | 2014 | 8 | 0.500 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2014 | 4 | 0.500 |
Why?
|
| RNA-Binding Proteins | 2 | 2014 | 68 | 0.490 |
Why?
|
| Ribonuclease III | 1 | 2014 | 3 | 0.480 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 9 | 0.480 |
Why?
|
| Phylogeny | 3 | 2023 | 58 | 0.480 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 354 | 0.470 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 162 | 0.460 |
Why?
|
| Methyltransferases | 2 | 2012 | 4 | 0.450 |
Why?
|
| Protein Binding | 6 | 2016 | 199 | 0.430 |
Why?
|
| Spermine | 1 | 2011 | 1 | 0.400 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 17 | 0.390 |
Why?
|
| Escherichia coli | 2 | 2020 | 83 | 0.370 |
Why?
|
| Amino Acid Sequence | 4 | 2020 | 283 | 0.360 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 249 | 0.360 |
Why?
|
| RNA, Catalytic | 1 | 2009 | 1 | 0.350 |
Why?
|
| Streptococcus pyogenes | 2 | 2019 | 17 | 0.340 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2020 | 24 | 0.340 |
Why?
|
| DNA Cleavage | 2 | 2019 | 4 | 0.330 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 137 | 0.330 |
Why?
|
| Hela Cells | 3 | 2020 | 88 | 0.300 |
Why?
|
| Models, Biological | 4 | 2011 | 373 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 213 | 0.290 |
Why?
|
| RNA, Small Nucleolar | 1 | 2006 | 1 | 0.290 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2006 | 4 | 0.290 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2020 | 60 | 0.280 |
Why?
|
| Structure-Activity Relationship | 2 | 2019 | 82 | 0.260 |
Why?
|
| Cytoplasm | 2 | 2016 | 32 | 0.260 |
Why?
|
| Animals | 6 | 2021 | 7318 | 0.260 |
Why?
|
| Gene Expression | 2 | 2020 | 333 | 0.250 |
Why?
|
| Protein Folding | 1 | 2023 | 28 | 0.230 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 35 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 1 | 2022 | 74 | 0.210 |
Why?
|
| Cell Line | 6 | 2015 | 455 | 0.210 |
Why?
|
| Pathology, Molecular | 1 | 2021 | 16 | 0.210 |
Why?
|
| Mutation | 3 | 2016 | 469 | 0.200 |
Why?
|
| Purine Nucleosides | 1 | 2020 | 1 | 0.200 |
Why?
|
| Pyrimidine Nucleosides | 1 | 2020 | 1 | 0.200 |
Why?
|
| Spermidine | 1 | 2020 | 2 | 0.200 |
Why?
|
| Subcellular Fractions | 1 | 2020 | 14 | 0.190 |
Why?
|
| Molybdenum | 1 | 2020 | 2 | 0.190 |
Why?
|
| Point Mutation | 1 | 2020 | 23 | 0.190 |
Why?
|
| Sodium Chloride | 1 | 2020 | 26 | 0.190 |
Why?
|
| Magnesium | 1 | 2020 | 22 | 0.190 |
Why?
|
| Trinucleotide Repeats | 1 | 2020 | 9 | 0.190 |
Why?
|
| Ink | 1 | 2020 | 11 | 0.190 |
Why?
|
| Disulfides | 1 | 2020 | 34 | 0.190 |
Why?
|
| Electrochemical Techniques | 1 | 2020 | 22 | 0.190 |
Why?
|
| DNA Restriction Enzymes | 1 | 2020 | 5 | 0.190 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2010 | 3 | 0.180 |
Why?
|
| Alleles | 2 | 2011 | 251 | 0.180 |
Why?
|
| Repressor Proteins | 2 | 2011 | 53 | 0.180 |
Why?
|
| Oligonucleotide Probes | 1 | 2019 | 3 | 0.180 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 93 | 0.180 |
Why?
|
| Tandem Repeat Sequences | 1 | 2019 | 5 | 0.170 |
Why?
|
| DNA, A-Form | 1 | 2019 | 1 | 0.170 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 45 | 0.170 |
Why?
|
| Archaea | 2 | 2009 | 3 | 0.160 |
Why?
|
| Protein Structure, Secondary | 2 | 2016 | 46 | 0.160 |
Why?
|
| Genotype | 1 | 2020 | 735 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2017 | 8 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 3 | 2012 | 95 | 0.150 |
Why?
|
| Brassica | 1 | 2016 | 1 | 0.140 |
Why?
|
| Spinacia oleracea | 1 | 2016 | 1 | 0.140 |
Why?
|
| X-Ray Diffraction | 1 | 2016 | 2 | 0.140 |
Why?
|
| Catalysis | 2 | 2020 | 64 | 0.130 |
Why?
|
| Base Pairing | 1 | 2015 | 4 | 0.130 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2015 | 5 | 0.130 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 15 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 26 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2014 | 801 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2013 | 519 | 0.120 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2013 | 4 | 0.120 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 42 | 0.120 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 10 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 50 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 73 | 0.110 |
Why?
|
| Binding Sites | 2 | 2011 | 125 | 0.110 |
Why?
|
| Peptide Nucleic Acids | 2 | 2011 | 3 | 0.110 |
Why?
|
| Cations | 1 | 2011 | 9 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 23 | 0.100 |
Why?
|
| Cell Membrane Permeability | 1 | 2011 | 16 | 0.100 |
Why?
|
| Molecular Structure | 1 | 2011 | 53 | 0.100 |
Why?
|
| Giardia lamblia | 1 | 2011 | 2 | 0.100 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2011 | 4 | 0.100 |
Why?
|
| Protozoan Proteins | 1 | 2011 | 9 | 0.100 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2010 | 2 | 0.100 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 69 | 0.100 |
Why?
|
| Circular Dichroism | 2 | 2011 | 30 | 0.100 |
Why?
|
| Ribonuclease H | 1 | 2010 | 7 | 0.100 |
Why?
|
| Temperature | 2 | 2011 | 57 | 0.100 |
Why?
|
| Models, Genetic | 1 | 2011 | 95 | 0.090 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2010 | 1 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 25 | 0.090 |
Why?
|
| Leigh Disease | 1 | 2010 | 1 | 0.090 |
Why?
|
| Farnesyltranstransferase | 1 | 2010 | 2 | 0.090 |
Why?
|
| Ubiquinone | 1 | 2010 | 8 | 0.090 |
Why?
|
| Lysosomes | 1 | 2010 | 10 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 13 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 23 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2009 | 21 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 37 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2010 | 226 | 0.090 |
Why?
|
| Sheep | 1 | 2010 | 221 | 0.090 |
Why?
|
| Anthracenes | 1 | 2009 | 1 | 0.090 |
Why?
|
| Ethylene Glycols | 1 | 2009 | 8 | 0.090 |
Why?
|
| Sesquiterpenes | 1 | 2009 | 5 | 0.090 |
Why?
|
| Lactones | 1 | 2009 | 11 | 0.090 |
Why?
|
| Piperidines | 1 | 2010 | 125 | 0.080 |
Why?
|
| Pyridines | 1 | 2009 | 78 | 0.080 |
Why?
|
| Dopamine | 1 | 2010 | 227 | 0.080 |
Why?
|
| Methylation | 1 | 2006 | 5 | 0.070 |
Why?
|
| Chromatography, Affinity | 1 | 2006 | 15 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 981 | 0.070 |
Why?
|
| Ferrocyanides | 1 | 2020 | 1 | 0.050 |
Why?
|
| Surface Properties | 1 | 2020 | 32 | 0.050 |
Why?
|
| Limit of Detection | 1 | 2020 | 15 | 0.050 |
Why?
|
| Electrodes | 1 | 2020 | 17 | 0.050 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2020 | 2 | 0.050 |
Why?
|
| Carbohydrate Conformation | 1 | 2020 | 2 | 0.050 |
Why?
|
| Luciferases, Firefly | 1 | 2020 | 3 | 0.050 |
Why?
|
| Molecular Weight | 2 | 2011 | 42 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 15 | 0.050 |
Why?
|
| Particle Size | 1 | 2020 | 42 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 71 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 250 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 20 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 100 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 81 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 147 | 0.030 |
Why?
|
| Histones | 1 | 2013 | 49 | 0.030 |
Why?
|
| Protein Stability | 1 | 2011 | 26 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 683 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2013 | 173 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 77 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 5 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 33 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2010 | 10 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 20 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 85 | 0.020 |
Why?
|
| Peptides | 1 | 2011 | 118 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2009 | 15 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2009 | 29 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2009 | 21 | 0.020 |
Why?
|
| Machado-Joseph Disease | 1 | 2009 | 1 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 321 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2009 | 103 | 0.020 |
Why?
|
| Mice | 1 | 2009 | 2380 | 0.010 |
Why?
|
| Male | 1 | 2009 | 17897 | 0.010 |
Why?
|
| Female | 1 | 2009 | 18271 | 0.010 |
Why?
|